Ladenburg Thalmann Financial Services’s Rocket Pharmaceuticals RCKT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-525	Closed	-$4K	–	4947
2017 Q1	$4K	Buy	525 +294	+127%	+$1.98K	﹤0.01%	4387
2016 Q4	$6K	Hold	231	–	–	﹤0.01%	4146
2016 Q3	$9K	Hold	231	–	–	﹤0.01%	3889
2016 Q2	$7K	Hold	231	–	–	﹤0.01%	3964
2016 Q1	$7K	Buy	231 +31	+16%	+$930	﹤0.01%	3896
2015 Q4	$9K	Hold	200	–	–	﹤0.01%	3742
2015 Q3	$8K	Buy	+200	New	+$9.18K	﹤0.01%	3679

Other funds holding RCKT

Rho Capital Partners New York $20.4M AUM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return